AVITA Medical, Inc. (RCEL)
15.29
+1.49
(+10.80%)
USD |
NASDAQ |
Oct 21, 16:00
15.25
-0.04
(-0.26%)
After-Hours: 20:00
AVITA Medical Net Income (Annual) : -48.59M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -48.59M |
| December 31, 2024 | -61.84M |
| December 31, 2023 | -35.38M |
| December 31, 2022 | -26.66M |
| June 30, 2021 | -26.58M |
| June 30, 2020 | -42.03M |
| June 30, 2019 | -25.14M |
| June 30, 2018 | -12.80M |
| June 30, 2017 | -8.681M |
| June 30, 2016 | -7.475M |
| June 30, 2015 | -5.920M |
| June 30, 2014 | -4.725M |
| June 30, 2013 | -8.303M |
| June 30, 2012 | -7.910M |
| Date | Value |
|---|---|
| June 30, 2011 | -1.772M |
| June 30, 2010 | -5.184M |
| June 30, 2009 | -3.772M |
| June 30, 2008 | -10.90M |
| June 30, 2007 | -11.82M |
| June 30, 2006 | -8.948M |
| June 30, 2005 | -7.118M |
| June 30, 2004 | -5.067M |
| June 30, 2003 | -2.308M |
| December 31, 2002 | -1.460M |
| December 31, 2001 | -1.307M |
| December 31, 2000 | -1.699M |
| December 31, 1999 | -0.8012M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Halozyme Therapeutics, Inc. | 316.89M |
| Iovance Biotherapeutics, Inc. | -390.98M |
| Agenus, Inc. | -3.083M |
| Amgen, Inc. | 7.711B |
| Editas Medicine, Inc. | -160.06M |